MiƱoza, Bonifacia .
HRN: 24-71-98 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/30/2025
CIPROFLOXACIN 500MG (TAB)
04/30/2025
05/06/2025
ORAL
750mg
Every 12hrs
Non Healing Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes